Albemarle (NYSE:ALB – Free Report) had its price target decreased by UBS Group from $142.00 to $137.00 in a research note released on Tuesday, Benzinga reports. UBS Group currently has a neutral rating on the specialty chemicals company’s stock. A number of other analysts have also commented on ALB. Bank of America upgraded Albemarle from […]